n 0861 has been researched along with bradykinin in 1 studies
| Studies (n 0861) | Trials (n 0861) | Recent Studies (post-2010) (n 0861) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 20 | 1 | 0 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | n 0861 (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannella, E; Levi, R; Mochmann, HC | 1 |
1 other study(ies) available for n 0861 and bradykinin
| Article | Year |
|---|---|
Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.
Topics: Adenine; Adenosine; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Guinea Pigs; Hypoxia; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Norbornanes; Receptor, Adenosine A3; Receptor, Bradykinin B2; Receptors, Bradykinin; Receptors, Purinergic P1; Vasodilation | 1997 |